HLS Therapeutics Inc. (FRA:74D)
2.860
+0.020 (0.70%)
At close: Dec 1, 2025
HLS Therapeutics Revenue
HLS Therapeutics had revenue of $13.51M USD in the quarter ending September 30, 2025, a decrease of -4.08%. This brings the company's revenue in the last twelve months to $55.85M, down -1.92% year-over-year. In the year 2024, HLS Therapeutics had annual revenue of $56.62M, down -10.23%.
Revenue (ttm)
$55.85M
Revenue Growth
-1.92%
P/S Ratio
1.98
Revenue / Employee
$607.03K
Employees
92
Market Cap
94.48M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.62M | -6.46M | -10.23% |
| Dec 31, 2023 | 63.07M | 1.61M | 2.61% |
| Dec 31, 2022 | 61.47M | 1.46M | 2.43% |
| Dec 31, 2021 | 60.01M | 3.90M | 6.95% |
| Dec 31, 2020 | 56.11M | 1.95M | 3.60% |
| Dec 31, 2019 | 54.16M | -7.26M | -11.81% |
| Dec 31, 2018 | 61.42M | -13.67M | -18.20% |
| Dec 31, 2017 | 75.08M | 21.05M | 38.96% |
| Dec 31, 2016 | 54.03M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |